A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer (BicaBCa)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05327647 |
|
Recruitment Status :
Recruiting
First Posted : April 14, 2022
Last Update Posted : February 7, 2024
|
Sponsor:
CHU de Quebec-Universite Laval
Collaborator:
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
CHU de Quebec-Universite Laval
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 1, 2024 |
| Estimated Study Completion Date : | December 31, 2026 |